Comment les cancers échappent-ils à la chimiothérapie ? = Resistance of cancer cells to chemotherapy and reversionPOUPON, M.-F.Pathologie et biologie. 1992, Vol 40, Num 9BIS, pp 923-927, issn 0369-8114Article

Les xénogreffes de cancer de l'Homme : l'opportunité de modéliser la maladie cancéreuse de l'Homme et son traitementPOUPON, M.-F.Annales de pathologie (Paris). 2006, Num NOV, issn 0242-6498, 1S51-1S53, HS1Conference Paper

Le processus métastatique = The metastatic processDESPLACES, A; POUPON, M. F.Bulletin du cancer. 1994, Vol 81, Num 9, pp 751-754, issn 0007-4551Article

Les bases moléculaires de l'invasivité des cellules tumorales = Molecular bases of tumoral cell invasivenessBURTIN, P; POUPON, M. F.Bulletin du cancer. 1992, Vol 79, Num 4, pp 313-314, issn 0007-4551Article

Enhancement of pulmonary metastases induced by decreased lung natural killer cell activityNOLIBE, D; POUPON, M. F.Journal of the National Cancer Institute. 1986, Vol 77, Num 1, pp 99-103, issn 0027-8874Article

Methionine dependency of malignant tumors : a possible approach for therapyBREILLOUT, F; ANTOINE, E; POUPON, M. F et al.Journal of the National Cancer Institute. 1990, Vol 82, Num 20, pp 1628-1632, issn 0027-8874Article

Cell surface glycosaminoglycans of rat rhabdomyosarcoma lines with different metastatic potentials and of non-malignant rat myoblastsREDINI, F; MOCZAR, E; POUPON, M. F et al.Biochimica et biophysica acta. 1986, Vol 883, Num 1, pp 98-105, issn 0006-3002Article

Perte d'un chromosome 10, altération du métabolisme lié à l'hexokinase, bases d'une approche thérapeutique des gliomes = Loss of chromosome-10, metabolic alteration due to hexokinase-I, rational for a new therapeutic approch in gliomaOudard, Stéphane; Poupon, M.-F.1996, 229 p.Thesis

Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressivenessWEISWALD, L.-B; RICHON, S; GAYET, B et al.British journal of cancer. 2009, Vol 101, Num 3, pp 473-482, issn 0007-0920, 10 p.Article

Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancerRICOL, D; CAPPELLEN, D; THIERY, J. P et al.Oncogene (Basingstoke). 1999, Vol 18, Num 51, pp 7234-7243, issn 0950-9232Article

S9788 modulation of P-glycoprotein- and multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cellsBICHAT, F; SOLIS-RECENDEZ, G; POULLAIN, M.-G et al.Biochemical pharmacology. 1998, Vol 56, Num 4, pp 497-502, issn 0006-2952Article

Preclinical antitumor activity of a New Vinca alkaloid derivative, S12363PEIRRE, A; KRAUS-BERTHIER, L; ATASSI, G et al.Cancer research (Baltimore). 1991, Vol 51, Num 9, pp 2312-2318, issn 0008-5472, 7 p.Article

Promotion of micrometastasis proliferation in a rat rhabdomyosarcoma model by epidermal growth factorBREILLOUT, F; ANTOINE, E; LASCAUV, V et al.Journal of the National Cancer Institute. 1989, Vol 81, Num 9, pp 702-705, issn 0027-8874Article

Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell lineNAZANINE MODJTAHEDI; LAVIALLE, C; POUPON, M.-F et al.Cancer research (Baltimore). 1985, Vol 45, Num 9, pp 4372-4379, issn 0008-5472Article

Establishment and characterisation of a new breast cancer ×enograft obtained from a woman carrying a germline BRCA2 mutationDE PLATER, L; LAUGE, A; BROUGH, R et al.British journal of cancer. 2010, Vol 103, Num 8, pp 1192-1200, issn 0007-0920, 9 p.Article

Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levelsGIOVANNETTI, E; BACKUS, H. H. J; WOUTERS, D et al.British journal of cancer. 2007, Vol 96, Num 5, pp 769-775, issn 0007-0920, 7 p.Article

Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatmentMICCOLI, L; POIRSON-BICHAT, F; SUREAU, F et al.Journal of the National Cancer Institute. 1998, Vol 90, Num 18, pp 1400-1406, issn 0027-8874Article

Correlation between reversion of a dedifferentiated rat hepatoma line and the recovery of tumorigenicityMAIGNE, J; KIM HENG NG; MEUNIER-ROTIVAL, M et al.Cancer research (Baltimore). 1988, Vol 48, Num 11, pp 3258-3264, issn 0008-5472Article

Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability : Influence of P53 statusPOCARD, M; BRAS-GONCALVES, R; HAMELIN, R et al.Anticancer research. 2000, Vol 20, Num 1A, pp 85-90, issn 0250-7005Article

Distinct chromosomal alterations associated with TP53 status of LoVo cells under PALA selective pressure : a parallel with cytogenetic pathways of colorectal cancersSOULIE, P; POUPON, M.-F; REMVIKOS, Y et al.Oncogene (Basingstoke). 1999, Vol 18, Num 3, pp 775-781, issn 0950-9232Article

Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell linesDANGLES, V; FEMENIA, F; LAINE, V et al.Cancer research (Baltimore). 1997, Vol 57, Num 16, pp 3360-3364, issn 0008-5472Article

Mitochondria-bound hexokinase as target for therapy of malignant gliomasOUDARD, S; POIRSON, F; MICCOLI, L et al.International journal of cancer. 1995, Vol 62, Num 2, pp 216-222, issn 0020-7136Article

Implantation orthotopique de cancers humains du côlon sur souris nude : méthodologie et intérêt physiopathologique : Tube digestif et pancréas = Orthotopic implantation of human colon cancer into nude mice. Methodology and pathophysiological interestTSUKUI, H; POCARD, M; SALMON, R.-J et al.Gastroentérologie clinique et biologique. 1994, Vol 18, Num 12, pp 1112-1118, issn 0399-8320Conference Paper

Page / 3